Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDevelop North Regulatory News (DVNO)

Share Price Information for Develop North (DVNO)

Share Price is delayed by 15 minutes
Get Live Data
76.50    0.00 (0.00%)
Bid:
73.00
Ask:
80.00
Spread: 7.00 (9.589%)
Market Cap: £19.91m
DVNO Live PriceLast checked at - London Stock Exchange

Intraday Develop North Share Chart

Net Asset Value(s)

30 Apr 2026 13:38

RNS Number : 6413C
Develop North PLC
30 April 2026
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO CANADA, JAPAN, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA OR THE UNITED STATES OF AMERICA OR TO US PERSONS, OR TO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

 

For release on 30 April 2026

 

DEVELOP NORTH PLC

LEI: 213800EXPWANYN3NEV68

 

(the 'Company' or 'DVNO')

 

Quarterly Net Asset Value as at 28 February 2026

 

 

 

The Company announces that its unaudited Net Asset Value ("NAV") per share as at 28 February 2026 on a cum-income basis was 77.60 pence, an increase of 0.12 pence per share as compared to the NAV per share as at 30 November 2025. 

 

 

 

Enquiries:

 

Develop North PLC Michelle Percy

Ian McElroy

+44 (0) 191 222 0099

 

 

Tier One Capital Ltd (Investment Adviser) Brendan O'Grady

+44 (0) 191 222 0099 

 

Cavendish Capital Markets Limited (Financial Adviser and Corporate Broker) Robert PeelAndrew WorneOscar Valeur-Adu

+44 (0) 207 220 0500

 

 

Alma Strategic Communications (Financial Communications Adviser) Andrew JaquesJoe PederzolliLouisa El-Ahwal

 

+44 (0) 203 405 0211

 

 

Apex Fund Administration Services (UK) Limited (Secretary) +44 (0) 1245 398950

Notes to Editors:

 

Develop North PLC's investment objective is to provide shareholders with a consistent and stable income and the potential for an attractive total return over the medium to long term, through a diversified portfolio of investments predominantly in the North East of England.

 

The Company has the financial strength, credibility and professionalism expected of a business listed on the London Stock Exchange, while also offering the flexibility, creativity and common sense of an approachable, local business.

 

Since the Company's IPO in 2017, it has invested almost £90 million of capital into the North of England and Scotland and has helped support an estimate 12,000 jobs with a gross development value of more than £280 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVLBLFXQZLXBBZ
12
Date   Source Headline
5th May 20261:58 pmRNSTotal Voting Rights
30th Apr 20261:41 pmRNSResult of Annual General Meeting
30th Apr 20261:38 pmRNSNet Asset Value(s)
14th Apr 202612:02 pmRNSChange of Venue for Annual General Meeting
31st Mar 20263:33 pmRNSResult of Equity Issue
24th Mar 20262:45 pmRNSChange of Registered Office
24th Mar 202612:17 pmRNSPublication of a Supplementary Prospectus
12th Mar 20266:20 pmRNSAnnual Financial Report
26th Feb 20262:14 pmRNSDividend Declaration
18th Feb 20262:18 pmRNSGeneral Meeting Result
26th Jan 20267:00 amRNSAppointment of Chief Executive Officer
20th Jan 20262:30 pmRNSChange of Registered Office
16th Jan 202611:12 amRNSRetail Offer
16th Jan 202611:11 amRNSPublication of a Prospectus
14th Jan 20267:00 amRNSNet Asset Value(s)
8th Dec 20259:33 amRNSDividend Declaration
10th Nov 20252:59 pmRNSNet Asset Value(s)
17th Oct 20253:31 pmRNSNon-material change to investment policy
29th Aug 20259:32 amRNSDividend Declaration
11th Aug 20257:00 amRNSHalf-year Report
9th Jul 20257:00 amRNSChange to Investment Policy & Potential Fundraise
4th Jun 20255:52 pmRNSDividend Declaration
2nd May 20257:00 amRNSAppointment of Non-Executive Director
1st May 20255:46 pmRNSResult of Annual General Meeting
1st May 202512:02 pmRNSNet Asset Value(s)
19th Mar 20252:29 pmRNSAnnual Financial Report
12th Mar 20255:24 pmRNSDividend Declaration
21st Nov 20242:35 pmRNSDividend Declaration
21st Nov 20242:31 pmRNSNet Asset Value(s)
30th Aug 20247:00 amRNSDividend Declaration
31st Jul 20242:07 pmRNSNet Asset Value(s)
31st Jul 20242:05 pmRNSHalf-year Report
31st May 202412:55 pmRNSDividend Declaration
1st May 20247:00 amRNSTotal Voting Rights
26th Apr 20247:05 amRNSResult of AGM
26th Apr 20247:00 amRNSNet Asset Value(s)
15th Apr 20241:49 pmRNSTransaction in Own Shares
12th Apr 20245:22 pmRNSTransaction in Own Shares
12th Apr 20244:23 pmRNSTransaction in Own Shares
4th Apr 20249:32 amRNSCommencement of New Share Buyback Programme
26th Mar 20247:00 amRNSAnnual Financial Report
29th Feb 202412:06 pmRNSDividend Declaration
2nd Jan 20249:29 amRNSTotal Voting Rights
21st Dec 20234:55 pmRNSTransaction in Own Shares
18th Dec 20234:45 pmRNSTransaction in Own Shares
13th Dec 20235:03 pmRNSTransaction in Own Shares
8th Dec 20235:01 pmRNSTransaction in Own Shares
7th Dec 20237:00 amRNSExtension of Share Buyback Programme
1st Dec 202312:49 pmRNSTotal Voting Rights
23rd Nov 202311:22 amRNSDividend Declaration
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.